XDEEP Recalls NX700 Regulators

The folks at XDEEP recently announced a voluntary recall of the company’s NX700 regulators.

While XDEEPhaven’t noticed a single failure caused by this, we decided to recall our NX700 regulators and update them to the newest version,” according to a Facebook post.

The notice continues:

“Our NX700 regulators are made for us in Italy, by a renowned manufacturer with many years of experience in this type of product. Before market launch, we have extensively tested them during many months of rigorous tests in extremely demanding conditions.

“Unfortunately, during routine periodical maintenance servicing of some NX700 1st stages, in singular cases, we have detected some traces above-standard signs of the wear of the membrane.

“We have not detected nor received any notifications about any failure or abnormalities caused by this potential wear. Nevertheless, we have decided to update all existing NX700 first stages to the newest available version, where any chances of the mentioned abnormalities have now been completely eliminated.

“If you are an owner of an NX700 1st stage, please stop using it immediately and contact the dealer where you’ve purchased the regulator, or us directly. Please follow this link to get full information about details of this action.

“To compensate for the inconvenience caused to our clients, we have also decided that every NX700 set owner will get a free XDEEP Signature Hoodie in the chosen size and available color.”

John Lianghttps://www.deeperblue.com/

John Liang is the News Editor at DeeperBlue.com. He first got the diving bug while in High School in Cairo, Egypt, where he earned his PADI Open Water Diver certification in the Red Sea off the Sinai Peninsula. Since then, John has dived in a volcanic lake in Guatemala, among white-tipped sharks off the Pacific Coast of Costa Rica, and other places including a pool in Las Vegas helping to break the world record for the largest underwater press conference.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Innovating manufacturing technology in emerging economies thumbnail

Innovating manufacturing technology in emerging economies

To the editor — Most US- and European-based drug makers that produce biosimilar products use decades-old processes for manufacturing. Although there is no business incentive for Western manufacturers to innovate in downstream processes, the situation is very different in emerging economies. Here, we highlight two Indian companies — Biocon and Enzene Biosciences (of Alkem Laboratories)
Read More
エティハド航空、A350F貨物機を7機発注へ thumbnail

エティハド航空、A350F貨物機を7機発注へ

 エアバスは現地時間2月16日、エティハド航空(ETD/EY)とA350F貨物機の導入に向けて基本合意書(LoI)を締結したと発表した。7機導入する計画で、同社のA350ファミリーは受領済みの5機のA350-1000と合わせて12機になる。 A350F貨物機のイメージ(エアバス提供)  開発中のA350Fは大型旅客機A350の貨物型で、最大離陸重量は319トン、ペイロードは最大109トン、航続距離は8700キロメートル(4700海里)。全長は70.8メートルで、A350-900の66.8メートルとA350-1000の73.79メートルの間の長さとなる。エアバスによると、胴体の長さと容量は、業界標準のパレットや貨物コンテナに最適化したといい、機体後部左側に貨物ドアを設けた。  エンジンは、ロールス・ロイスのA350向けエンジン「Trent XWB(トレントXWB)」のうち、A350-1000向けのTrent XWB-97が採用された。燃費とCO2(二酸化炭素)排出量はボーイング777F貨物機と比べて20%以上少なくなるという。また、2027年に発効するICAO(国際民間航空機関)のCO2排出基準をクリアする。  これまでに11機の確定発注を獲得しており、コミットメントを含めると5社29機。2025年に就航予定で、シンガポール航空(SIA/SQ)が世界で初めてA350Fを運航する航空会社になる見込み。 関連リンクエティハド航空Airbus A350F ・シンガポール航空、A350F貨物機を7機発注へ 25年から747-400F置き換え(21年12月15日) ・CMA CGMエアカーゴ、A350Fを4機発注(21年11月21日) ・ALC、エアバス機111機発注へ A350F貨物機も(21年11月16日) ・エアバス、A350貨物型開発へ 25年就航視野(21年7月31日)
Read More
Laser Flashes for Cancer Research – Milestone in Proton Irradiation Achieved thumbnail

Laser Flashes for Cancer Research – Milestone in Proton Irradiation Achieved

A research team led by the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has successfully tested the irradiation of tumors with laser protons for the first time. Credit: HZDR / Juniks Irradiation with fast protons is a more effective and less invasive cancer treatment than X-rays. However, modern proton therapy requires large particle accelerators, which has experts investigating alternative…
Read More
COVID in a cat thumbnail

COVID in a cat

Since being identified in people in 2019, SARS-CoV-2 has gone on to infect a wide range of animal species, wild and domestic. Concerns abound that these species jumps could lead to novel mutations and even harmful new variants. In a new report, researchers from the University of Pennsylvania's School of Veterinary Medicine and Perelman School…
Read More
A common parasite could deliver drugs to the brain—how scientists are turning Toxoplasma gondii from foe into friend thumbnail

A common parasite could deliver drugs to the brain—how scientists are turning Toxoplasma gondii from foe into friend

Parasites take an enormous toll on human and veterinary health. But researchers may have found a way for patients with brain disorders and a common brain parasite to become frenemies. A new study published in Nature Microbiology has pioneered the use of a single-celled parasite, Toxoplasma gondii, to inject therapeutic proteins into brain cells. The
Read More
Index Of News
Total
0
Share